The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

integritylaboratories.com

About Integrity Laboratories

Integrity Laboratories provides clinical laboratory testing on behalf of its client base.

Integrity Laboratories Headquarter Location

830 Corridor Park Boulevard Suite 400

Knoxville, Tennessee, 37932,

United States

(844) 658-5745

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Integrity Laboratories News

Integrity Laboratories Launches Novel Quantification Tool For COVID-19 Providers

Jan 26, 2021

Integrity Laboratories Launches Novel Quantification Tool For COVID-19 Providers Knoxville Based Biotechnology Firm Introduces Newest Technology Helping Providers Diagnose and Treat COVID-19 with Greater Efficiency Author: Jan 26, 2021 8:46 AM EST KNOXVILLE, Tenn., Jan. 26, 2021 /PRNewswire/ --  Integrity Laboratories announced today, the launch of the first commercially available quantitative index to accompany positive COVID-19 specimen resulted through their EUA approved platform. The feature, known as AmpliteCt™, is a viral load indicator (VLI) and is achieved through an automated, quantitative methodology that categorizes the concentration of viral genetic material in a patient specimen. The AmpliteCt™ algorithm leverages several key data points, including cycle threshold (Ct), to accurately stratify COVID-19 positive patients within low, moderate, or high infection designations. "The AmpliteCt™ Viral Load Indicator utilizes the ability of a real time reverse transcriptase polymerase chain reaction (RT-PCR) technology to quantify the pathogen's genetic material in a patient sample in a very short time with high sensitivity and specificity, "said Maria Cekanova, RNDr, Ph.D, Chief Scientific Officer for Integrity Laboratories . "We are excited to begin deploying this much needed advancement in technology to our healthcare partners."   AmpliteCt™ VLI was developed by GenomIQ, a division of Integrity Laboratories focused on research and innovation of novel diagnostic technologies. Work began on the quantitative based approach to COVID-19 in September and was accelerated in conjunction with existing healthcare partnerships and validation studies. "The AmpliteCt™ technology advancement into viral load visibility is game changing for clinicians as they seek to triage the clinical needs of their patients," Said Christian Clevenger, Integrity Laboratories Chief Executive Officer . "Having access to quantifiable indexing also helps to identify those that may be candidates for viral load mediated therapies such as convalescent plasma. We are very proud of our team and their pioneering work in advancing diagnostic accuracy for COVID-19. "  ABOUT INTEGRITY LABORATORIES Integrity Laboratories  is the leading biotechnology firm committed to modernizing infectious disease management through high-complexity clinical diagnostics. Integrity Laboratories has pioneered antimicrobial stewardship with the introduction of Intercept PCR™, a molecular diagnostics platform that enables providers to order same-day and next-day diagnostic data on complicated patient conditions through non-invasive methods. Integrity Laboratories partners with the most trusted healthcare systems, providers, and insurance networks to deliver best-in-class technologies that lower costs and improve outcomes. Media Contact: Kelly Allen 289960@email4pr.com   1-844-658-5745 x110 View original content to download multimedia: http://www.prnewswire.com/news-releases/integrity-laboratories-launches-novel-quantification-tool-for-covid-19-providers-301215123.html SOURCE Integrity Laboratories

Integrity Laboratories Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Integrity Laboratories Rank

  • Where is Integrity Laboratories's headquarters?

    Integrity Laboratories's headquarters is located at 830 Corridor Park Boulevard, Knoxville.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.